These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37231616)

  • 1. Exudative age-related macular degeneration lesion components predicting microperimetric retinal sensitivity during anti-vascular endothelial growth factor treatment.
    Bygglin H; Immonen I; Luoma A; Hautamäki A
    Acta Ophthalmol; 2024 Feb; 102(1):107-115. PubMed ID: 37231616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between components of newly diagnosed exudative age-related macular degeneration lesion and focal retinal sensitivity.
    Hautamäki A; Oikkonen J; Onkamo P; Immonen I
    Acta Ophthalmol; 2014 Feb; 92(1):51-8. PubMed ID: 22998103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration.
    Kim M; Kim ES; Seo KH; Yu SY; Kwak HW
    Indian J Ophthalmol; 2016 Jun; 64(6):427-33. PubMed ID: 27488150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
    Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N
    Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOUBLE RETINAL PIGMENT EPITHELIUM TEARS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Mouallem A; Sarraf D; Chen X; Capuano V; Souied EH; Querques G
    Retina; 2016 Nov; 36(11):2197-2204. PubMed ID: 27145251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of anti-VEGF therapy for neovascular age-related macular degeneration in different types of exudative fluid localization].
    Budzinskaya MV; Afanasyeva MA; Plyukhova AA; Novikov IA; Shelankova AV; Andreeva IV
    Vestn Oftalmol; 2021; 137(6):12-17. PubMed ID: 34965062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration.
    Schütze C; Wedl M; Baumann B; Pircher M; Hitzenberger CK; Schmidt-Erfurth U
    Am J Ophthalmol; 2015 Jun; 159(6):1100-1114.e1. PubMed ID: 25769245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab Treatment.
    Kuehlewein L; Dustin L; Sagong M; Hariri A; Mendes TS; Rofagha S; Bhisitkul RB; Sadda SR
    Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):224-31. PubMed ID: 26985795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PREDICTING RESPONSE OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION TO BEVACIZUMAB BASED ON SPECTRALIS OPTICAL COHERENCE TOMOGRAPHY.
    Segal O; Barayev E; Nemet AY; Mimouni M
    Retina; 2016 Feb; 36(2):259-63. PubMed ID: 26200510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATT.
    Toth CA; Tai V; Pistilli M; Chiu SJ; Winter KP; Daniel E; Grunwald JE; Jaffe GJ; Martin DF; Ying GS; Farsiu S; Maguire MG;
    Ophthalmol Retina; 2019 Apr; 3(4):316-325. PubMed ID: 31014683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
    Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
    Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal pigment epithelial characteristics in eyes with neovascular age-related macular degeneration : Long-term retinal changes under anti-vascular endothelial growth factor treatment.
    Ebner C; Wernigg C; Schütze C; Weingessel B; Vécsei-Marlovits PV
    Wien Klin Wochenschr; 2021 Feb; 133(3-4):123-130. PubMed ID: 32761460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography.
    Nagiel A; Sarraf D; Sadda SR; Spaide RF; Jung JJ; Bhavsar KV; Ameri H; Querques G; Freund KB
    Retina; 2015 Apr; 35(4):638-47. PubMed ID: 25650713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors and a customized approach to anti-VEGF therapy for exudative age-related macular degeneration. Analysis of the risk of macular atrophy development].
    Yusef YN; Budzinskaya MV; Plyukhova AA
    Vestn Oftalmol; 2023; 139(3. Vyp. 2):51-55. PubMed ID: 37144369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration.
    Chan CK; Abraham P; Sarraf D; Nuthi AS; Lin SG; McCannel CA
    Eye (Lond); 2015 Jan; 29(1):80-7. PubMed ID: 25277305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.